RecruitingNot ApplicableNCT07119489

A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial


Sponsor

Wake Forest University Health Sciences

Enrollment

16 participants

Start Date

Feb 11, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research study is to learn more about how Dialectical Behavior Therapy - Skills Training can help patients with cancer who smoke cigarettes cut down on or stop their smoking.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • Smoke ≥1 cigarettes every day in the past 30 days per participant report.
  • Smoked at least 100 cigarettes (5 packs) in lifetime.
  • Confirmation of cancer diagnosis at any time.
  • Patient encounter with an AHWFBCCC provider within the last two years.
  • Age ≥ 18 years at the time of consent.
  • Ability to understand and willingness to sign an IRB-approved informed consent, in English, directly.
  • Able and willing to participate in video conference.

Exclusion Criteria5

  • Patients actively receiving external tobacco use counseling or using tobacco cessation medications.
  • Prior experience with more than five sessions of DBT-ST.
  • Medical or psychiatric conditions limiting compliance with study requirements including suspected or reported cognitive impairment.
  • Self-reported use of any psychoactive substance \[except marijuana and nicotine\] within the last 30 days.
  • Have active and severe suicidal ideation at time of eligibility assessment or suicide attempt within the past month.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALDialectical Behavior Therapy -Skill Training brief intervention

A behavioral counseling approach for enhancing skills in emotion regulation, distress tolerance, and mindfulness


Locations(2)

Atrium Health Levine Cancer

Charlotte, North Carolina, United States

Atrium Health Wake Forest Baptist Comprehensive Cancer Center

Winston-Salem, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07119489


Related Trials